Cargando…
Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double‐blind, placebo‐controlled trial
AIM: No effective pharmacological interventions have been developed for patients with methamphetamine use disorder. Ifenprodil is a blocker of G protein‐activated inwardly rectifying potassium channels, which play a key role in the mechanism of action of addictive substances. We conducted a randomiz...
Autores principales: | Kotajima‐Murakami, Hiroko, Takano, Ayumi, Hirakawa, Shinya, Ogai, Yasukazu, Funada, Daisuke, Tanibuchi, Yuko, Ban, Eriko, Kikuchi, Minako, Tachimori, Hisateru, Maruo, Kazushi, Kawashima, Takahiro, Tomo, Yui, Sasaki, Tsuyoshi, Oi, Hideki, Matsumoto, Toshihiko, Ikeda, Kazutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919120/ https://www.ncbi.nlm.nih.gov/pubmed/35068087 http://dx.doi.org/10.1002/npr2.12232 |
Ejemplares similares
-
Study of effects of ifenprodil in patients with methamphetamine dependence: Protocol for an exploratory, randomized, double‐blind, placebo‐controlled trial
por: Kotajima‐Murakami, Hiroko, et al.
Publicado: (2019) -
A randomized controlled study of the effect of ifenprodil on alcohol use in patients with alcohol dependence
por: Sugaya, Nagisa, et al.
Publicado: (2018) -
Activation of NMDA receptors and the mechanism of inhibition by ifenprodil
por: Tajima, Nami, et al.
Publicado: (2016) -
Single-trial neuromagnetic analysis reveals somatosensory dysfunction in chronic Minamata disease
por: Nakamura, Masaaki, et al.
Publicado: (2023) -
Family Dysfunction Differentially Affects Alcohol and Methamphetamine Dependence: A View from the Addiction Severity Index in Japan
por: Sugaya, Nagisa, et al.
Publicado: (2011)